Karyopharm Therapeutics (KPTI)
(Delayed Data from NSDQ)
$1.06 USD
-0.03 (-2.75%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $1.06 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -0.33 |
EPS Last Quarter | -0.36 |
Last EPS Surprise | -24.14% |
ABR | 1.43 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.19 |
Next Year | -1.05 |
EPS (TTM) | -1.25 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 35.02M | 36.66M | 148.39M | 176.44M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 38.36M | 39.40M | 150.85M | 209.72M |
Low Estimate | 31.70M | 34.60M | 144.00M | 141.50M |
Year ago Sales | 38.70M | 37.58M | 146.03M | 148.39M |
Year over Year Growth Est. | -9.51% | -2.46% | 1.61% | 18.90% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.33 | -0.31 | -1.19 | -1.05 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | -0.34 | -0.34 | -1.32 | -1.21 |
High Estimate | -0.28 | -0.27 | -1.09 | -0.77 |
Low Estimate | -0.37 | -0.34 | -1.32 | -1.27 |
Year ago EPS | -0.30 | -0.29 | -1.25 | -1.19 |
Year over Year Growth Est. | -10.00% | -6.90% | 4.80% | 11.97% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 4 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.33 | -0.31 | -1.19 | -1.05 |
7 Days Ago | -0.33 | -0.31 | -1.19 | -1.05 |
30 Days Ago | -0.33 | -0.31 | -1.15 | -1.02 |
60 Days Ago | -0.25 | -0.26 | -1.04 | -0.98 |
90 Days Ago | -0.27 | -0.28 | -1.04 | -0.92 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.33 | -0.31 | -1.19 | -1.05 |
Zacks Consensus Estimate | -0.33 | -0.31 | -1.19 | -1.05 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.36 | -0.30 | -0.29 | -0.30 | NA |
Estimate | -0.29 | -0.28 | -0.34 | -0.34 | NA |
Difference | -0.07 | -0.02 | 0.05 | 0.04 | 0.00 |
Surprise | -24.14% | -7.14% | 14.71% | 11.76% | -1.20% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more